成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 19798-80-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 19798-80-2
Chemical Structure| 19798-80-2
Structure of 19798-80-2 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 19798-80-2 ]

Related Doc. of [ 19798-80-2 ]

Alternatived Products of [ 19798-80-2 ]
Product Citations

Product Details of [ 19798-80-2 ]

CAS No. :19798-80-2 MDL No. :MFCD04113820
Formula : C5H5ClN2 Boiling Point : -
Linear Structure Formula :- InChI Key :RQMWVVBHJMUJNZ-UHFFFAOYSA-N
M.W : 128.56 Pubchem ID :581866
Synonyms :
Chemical Name :4-Chloropyridin-2-amine

Calculated chemistry of [ 19798-80-2 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 8
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 1.0
Molar Refractivity : 33.65
TPSA : 38.91 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.28 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.26
Log Po/w (XLOGP3) : 1.13
Log Po/w (WLOGP) : 1.33
Log Po/w (MLOGP) : 0.81
Log Po/w (SILICOS-IT) : 1.37
Consensus Log Po/w : 1.18

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.9
Solubility : 1.6 mg/ml ; 0.0125 mol/l
Class : Very soluble
Log S (Ali) : -1.54
Solubility : 3.7 mg/ml ; 0.0288 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.24
Solubility : 0.735 mg/ml ; 0.00571 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.39

Safety of [ 19798-80-2 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 19798-80-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 19798-80-2 ]
  • Downstream synthetic route of [ 19798-80-2 ]

[ 19798-80-2 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 19798-80-2 ]
  • [ 188577-68-6 ]
YieldReaction ConditionsOperation in experiment
69% With N-chloro-succinimide In N,N-dimethyl-formamide at -20 - 20℃; for 24 h; 5.2.2.30
7,8-Dichloro-1,4-dihydropyrido[2,3-b]pyrazine-2,3-dione (30)
To a solution of 2-amino-4-chloropyridine (1.28 g, 10.0 mmol) in DMF (40 mL) at -20 °C was added NCS (2.67 g, 20.0 mmol).
This mixture was allowed to warm to room temperature and stirred for 24 h, and then poured into 300 mL ice-water and extracted with ethyl acetate.
The extracts were washed with 1 M NaOH and brine, dried and evaporated.
The residue was purified by column chromatography on silica gel to give 4,5-dichloropyridin-2-amine (1.12 g, 69.0percent).
66% With N-chloro-succinimide In ethyl acetate at 20℃; for 28 h; INTERMEDIATE 1 4,5-Dichloropyridin-2-amine To a solution of 4-chloropyridine-2-amine (50.00 g, 0.389 mol) in EtOAc (400 mL) was added N-chloro succinimide (53.50 g, 0.401 mol) in one portion. The mixture was stirred over night (28 h) at room temperature, and was then filtered to remove precipitated succinimide. The filtrate was washed with aqueous 0.5M NaOH (8x50 mL), water (2x50 mL) and brine (2x50 mL). The organic phase was dried (Na2S04), filtered and evaporated to furnish 59.4 g of crude light brown powder after vacuum drying. The dry isolated crude (with a purity of ca. 75percent of the title compound) was slurried in hexane (800 mL) and stirred at reflux temperature for 15 min. The mixture was allowed to cool to 35 °C and was then filtered using a G3 glass frit filter. The filter cake was washed with hexane (ca. 200 mL) and dried on the filter to furnish 42.1 g (66percent>) of brown solid. The product was pure enough (96percent>) to be taken to the next step. 1H NMR (600 MHz, DMSO-d6) δ ppm 8.02 (s, 1 H) 6.65 (s, 1 H) 6.42 (s, 2 H). MS: (ESI+) m z 163, 165, 167 [M+H]+, di-chlorine isotopic pattern.
66% With N-chloro-succinimide In ethyl acetate at 20℃; for 28 h; To a solution of 4-chloropyridine-2-amine (50.00 g, 0.389 mol) in EtOAc (400 mL) was added N-chloro succinimide (53.50 g, 0.401 mol) in one portion. The mixture was stirred over night (28 h) at room temperature, and was then filtered to remove precipitated succinimide. The filtrate was washed with aqueous 0.5M NaOH (8x50 mL), water (2x50 mL) and brine (2x50 mL). The organic phase was dried (Na2SO4), filtered and evaporated to furnish 59.4 g of crude light brown powder after vacuum drying. The dry isolated crude (with a purity of ca. 75percent of the title compound) was slurried in hexane (800 mL) and stirred at reflux temperature for 15 min. The mixture was allowed to cool to 35 C and was then filtered using a G3 glass frit filter. The filter cake was washed with hexane (ca.200 mL) and dried on the filter to furnish 42.1 g (66percent) of brown solid. The product was pure enough (96percent) to be taken to the next step.1H NMR (600 MHz, DMSO-d6) δ ppm 8.02 (s, 1 H) 6.65 (s, 1 H) 6.42 (s, 2 H). MS: (ESI+) m/z 163, 165, 167 [M+H]+ , di-chlorine isotopic pattern.
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 1, p. 60 - 67
[2] European Journal of Medicinal Chemistry, 2016, vol. 117, p. 19 - 32
[3] Patent: WO2016/124553, 2016, A1, . Location in patent: Page/Page column 71-72
[4] Patent: WO2018/11138, 2018, A1, . Location in patent: Page/Page column 69-70
[5] Synthetic Communications, 1997, vol. 27, # 5, p. 861 - 870
[6] Patent: WO2011/85126, , A1, . Location in patent: Page/Page column 162-163[6] Patent: , 2011, , . Location in patent: Page/Page column 162-163
[8] Patent: US2016/362407, 2016, A1,
  • 2
  • [ 19798-80-2 ]
  • [ 188577-69-7 ]
  • [ 55933-91-0 ]
  • [ 188577-68-6 ]
Reference: [1] Synthetic Communications, 1997, vol. 27, # 5, p. 861 - 870
[2] Synthetic Communications, 1997, vol. 27, # 5, p. 861 - 870
  • 3
  • [ 19798-80-2 ]
  • [ 98-80-6 ]
  • [ 21203-86-1 ]
YieldReaction ConditionsOperation in experiment
75% With tetrakis(triphenylphosphine) palladium(0); sodium carbonate In ethanol; water; toluene at 90℃; for 14 h; Sealed tube; Inert atmosphere A mixture of 4-chloropyridin-2-amine (64 g, 498 mmol), phenyl boronic acid (61 g, 500 mmol), Na2CO3 (159 g, 1.5 mol), Pd(PPh3)4 (6.4 g) in H20/EtOH/toluene (500 mL) was heated to 90 °C in sealed vessel for 14 h. The crude mixture was cooled, filtered, and concentrated under reduced pressure. Purification (FCC, 5i02,PE:EtOAc (100:1) afforded the title Compound (64 g, 75percent).
Reference: [1] Patent: WO2017/100662, 2017, A1, . Location in patent: Page/Page column 103; 117
  • 4
  • [ 19798-80-2 ]
  • [ 670253-37-9 ]
YieldReaction ConditionsOperation in experiment
90% With N-iodo-succinimide In N,N-dimethyl-formamide for 43 h; General procedure: 36 (1.00g, 7.78mmol) was dissolved in DMF (40mL), the reaction flask was covered with aluminium foil, and NIS (970mg, 4.28mmol) was added. The reaction mixture was stirred for 19h before additional NIS (970mg, 4.28mmol) was added, and the reaction mixture was stirred for another 24h. H2O (200mL) was added, and the mixture was extracted with EtOAc (2×250mL). The combined organic layer was washed with H2O (2×200mL) and brine (200mL), dried over Na2SO4, and evaporated under vacuum. Recrystallization from EtOH followed by recrystallization of the mother liquor afforded the product as orange, needle-shaped crystals (1.45g, 73percent).
70% With N-iodo-succinimide In N,N-dimethyl-formamide at 40℃; A mixture of 4-chloropyridin-2-amine (2 g, 15.6 mmol) and N-iodosuccinimide (4.2 g, 18.7 mmol) in DMF (20 mL) was heated at 40°C overnight. The reaction mixture was diluted by H20 (80 mL), extracted by EtOAc (40 mL*3). The combined organic solutions were dried over Na2S04, filtered and concentrated under reduced pressure. The residue was purified by silica gel chromatography using Petroleum Ether:EtOAc (4: 1 ) as eluting solvents to afford 4-chloro-5-iodopyridin-2-amine as a red solid (2.8 g, 70percent). MS (ESI) m/z: 255 [M+H]+.
62% With N-iodo-succinimide In N,N-dimethyl-formamide at 20℃; for 18 h; To a solution of 2-amino-4-chloropyridine (150 g, 0.78 mol) in DMF (1.5 L) was added NIS (341 g, 1.52 mol) and the reaction mixture stirred at RT for 18 h before being concentrated in vacuo to 300 mL volume. The resultant residue was poured into 10percent aqueous sodium thiosulfate solution (1.2 L), stirred for 15 min and the precipitate formed collected by filtration, washed with water then dried at 35° C. in vacuo to give the title compound as a pale brown solid (185 g, 62percent). 1H NMR 400 MHz (CDCl3) δ: 8.33 (1H, s), 6.68 (1H, s), 4.52 (2H, s).
60% With N-iodo-succinimide In N,N-dimethyl-formamide at 20℃; for 18 h; (A. Tsuruoka, T. Matsushima, K. Miyazaki, J. Kamata, Y. Fukuda, K. Takahashi and M. Matsukura, Int. Pat. Appl. WO 200420434, 2005): N-iodosuccinimide (9.10 g, 40.4 mmol) was added to a solution of 2-amino-4- chloropyridine (i) (4.00 g, 31.1 mmol) in DMF (40 mL). The reaction mixture was stirred at room temperature for 18 h and partitioned between EtOAc (150 mL) and aqueous sodium thiosulfate solution (1M, 100 mL). The organic fraction was separated, washed successively with water (2 x 100 mL) and brine (50 mL), dried (MgS04) and reduced in vacuo to give the crude product as a light orange solid. Column chromatography (Si02), eluting with 5: 1 Petrol-EtOAc to 2: 1 Petrol-EtOAc, afforded compound ii. (4.65 g, 18.4 mmol, 60percent) as colourless needles, [M+H]+ m/z = 254.8.
60% With N-iodo-succinimide In N,N-dimethyl-formamide at 20℃; for 18 h; N-Iodosuccinimide (9.10 g, 40.4 mmol) was added to a solution of 2-amino-4-chloropyridine 29 (4.00 g, 31.1 mmol) in DMF (40 mL). The reaction mixture was stirred at room temperature for 18 h and partitioned between EtOAc (150 mL) and aqueous sodium thiosulfate solution (1M, 100 mL). The organic fraction was separated, washed successively with water (2 × 100 mL) and brine (50 mL), dried (MgSO4) and reduced in vacuo to give the crude product as a light orange solid. Column chromatography (SiO2), eluting with 5:1 Petrol–EtOAc to 2:1 Petrol–EtOAc, afforded the title compound16 (4.65 g, 18.4 mmol, 60percent) as colourless needles, m.p. 117-120 °C (from EtOH–water); Rf 0.57 (1:1 Petrol–EtOAc); (Found: C, 24.1; H, 1.50; N, 11.4; C5H4ClIN2 requires C, 23.6; H, 1.55; N, 11.0percent); δH (300 MHz, DMSO-d6); 8.21 (1H, s, 6-H), 6.69 (1H, s, 3-H), 6.43 (2H, br s, 2-NH2); δC (75 MHz, DMSO-d6); 160.8 (2-C), 156.2 (6-C), 146.3 (4-C), 108.7 (5-C), 79.4 (3-C); νmax/cm-1 (solid); 3436, 3284, 3121, 1629 and 1576; m/z (ES) 254.8 (100percent, MH+); (Found MH+, 254.9182. C5H4ClIN2 requires MH 254.9180); LC-MS; RT= 1.37min, m/z (ES+) found MH+, 254.8.

Reference: [1] European Journal of Medicinal Chemistry, 2014, vol. 84, p. 404 - 416
[2] Patent: WO2015/100609, 2015, A1, . Location in patent: Page/Page column 47
[3] Patent: US2012/245144, 2012, A1, . Location in patent: Page/Page column 125-126
[4] Journal of Medicinal Chemistry, 2016, vol. 59, # 3, p. 985 - 1002
[5] Patent: WO2013/91011, 2013, A1, . Location in patent: Page/Page column 64
[6] European Journal of Medicinal Chemistry, 2014, vol. 86, p. 31 - 38
[7] Patent: EP1522540, 2005, A1, . Location in patent: Page/Page column 125
  • 5
  • [ 19798-80-2 ]
  • [ 942947-95-7 ]
Reference: [1] Journal of Medicinal Chemistry, 2012, vol. 55, # 20, p. 8721 - 8734,14
[2] Journal of Medicinal Chemistry, 2012, vol. 55, # 20, p. 8721 - 8734
[3] Patent: WO2013/190320, 2013, A1,
[4] European Journal of Medicinal Chemistry, 2016, vol. 117, p. 19 - 32
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 19798-80-2 ]

Chlorides

Chemical Structure| 188577-68-6

[ 188577-68-6 ]

4,5-Dichloropyridin-2-amine

Similarity: 0.89

Chemical Structure| 364757-36-8

[ 364757-36-8 ]

4-Chloro-2-hydrazinylpyridine

Similarity: 0.88

Chemical Structure| 1227595-52-9

[ 1227595-52-9 ]

4-Chloro-3-methylpyridin-2-amine

Similarity: 0.86

Chemical Structure| 36340-61-1

[ 36340-61-1 ]

2-Amino-4-chloro-6-picoline

Similarity: 0.86

Chemical Structure| 116632-24-7

[ 116632-24-7 ]

2-Amino-4,6-dichloropyridine

Similarity: 0.82

Amines

Chemical Structure| 188577-68-6

[ 188577-68-6 ]

4,5-Dichloropyridin-2-amine

Similarity: 0.89

Chemical Structure| 364757-36-8

[ 364757-36-8 ]

4-Chloro-2-hydrazinylpyridine

Similarity: 0.88

Chemical Structure| 1227595-52-9

[ 1227595-52-9 ]

4-Chloro-3-methylpyridin-2-amine

Similarity: 0.86

Chemical Structure| 36340-61-1

[ 36340-61-1 ]

2-Amino-4-chloro-6-picoline

Similarity: 0.86

Chemical Structure| 116632-24-7

[ 116632-24-7 ]

2-Amino-4,6-dichloropyridine

Similarity: 0.82

Related Parent Nucleus of
[ 19798-80-2 ]

Pyridines

Chemical Structure| 188577-68-6

[ 188577-68-6 ]

4,5-Dichloropyridin-2-amine

Similarity: 0.89

Chemical Structure| 364757-36-8

[ 364757-36-8 ]

4-Chloro-2-hydrazinylpyridine

Similarity: 0.88

Chemical Structure| 1227595-52-9

[ 1227595-52-9 ]

4-Chloro-3-methylpyridin-2-amine

Similarity: 0.86

Chemical Structure| 36340-61-1

[ 36340-61-1 ]

2-Amino-4-chloro-6-picoline

Similarity: 0.86

Chemical Structure| 116632-24-7

[ 116632-24-7 ]

2-Amino-4,6-dichloropyridine

Similarity: 0.82

; ;